BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...
Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead’s Kite Pharma to treat relapsed or ...
Investopedia on MSN11h
Nvidia Stock Surges To Regain Position as World's Most Valuable CompanyWilliam Blair analysts on Monday raised their revenue and profit estimates for Nvidia over the next two fiscal years, citing ...
14h
William Blair analyst Louie DiPalma has maintained their bearish stance on PLTR stock, giving a Sell rating yesterday. Louie DiPalma has given ...
Glaukos Corporation's Q3 revenue grew 24% to $96.7 million, beating estimates, with an EPS loss of $(0.28). 2024 sales guidance raised despite anticipated headwinds.
Morgan Stanley's Keith Weiss took an unusual approach to backing away from his bearish stance on Tuesday, as he moved from an underweight call to a "not-rated" position in the wake of earnings.
Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback